375 related articles for article (PubMed ID: 28624360)
21. Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
Zilberszac R; Chandiramani R; Hengstenberg C; Sartori S; Cao D; Chandrasekhar J; Schafer U; Tchetche D; Violini R; Jeger R; Van Belle E; Boekstegers P; Hambrecht R; Tron C; Dumenteil N; Linke A; Ten Berg JM; Deliargyris EN; Anthopoulos P; Mehran R; Dangas G
Catheter Cardiovasc Interv; 2020 Sep; 96(3):E377-E386. PubMed ID: 31808295
[TBL] [Abstract][Full Text] [Related]
22. Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis.
Olmedo W; Villablanca PA; Sanina C; Walker J; Weinreich M; Brevik J; Avendano R; Bravo CA; Romero J; Ramakrishna H; Babaev A; Attubato M; Hernandez-Suarez DF; Cox-Alomar P; Pyo R; Krishnan P; Wiley J
Vascular; 2019 Feb; 27(1):78-89. PubMed ID: 30501582
[TBL] [Abstract][Full Text] [Related]
23. Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial.
Sanborn TA; Tomey MI; Mehran R; Généreux P; Witzenbichler B; Brener SJ; Kirtane AJ; McAndrew TC; Kornowski R; Dudek D; Nikolsky E; Stone GW
Catheter Cardiovasc Interv; 2015 Feb; 85(3):371-9. PubMed ID: 25179260
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
Cortese B; Micheli A; Picchi A; Bandinelli L; Brizi MG; Severi S; Limbruno U
Coron Artery Dis; 2009 Aug; 20(5):348-53. PubMed ID: 19543084
[TBL] [Abstract][Full Text] [Related]
26. Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.
Khambatta S; Othman H; Seth M; Lalonde T; Rosman HS; Gurm HS; Mehta RH;
Cardiovasc Revasc Med; 2016 Jun; 17(4):233-40. PubMed ID: 26994504
[TBL] [Abstract][Full Text] [Related]
27. Scientific foundation and possible implications for practice of the Minimizing Adverse Haemorrhagic Events by Transradial Access Site andSystemic Implementation of AngioX (MATRIX) trial.
Valgimigli M; Calabrò P; Cortese B; Frigoli E; Garducci S; Rubartelli P; Andò G; Santarelli A; Galli M; Garbo R; Repetto A; Ierna S; Briguori C; Limbruno U; Violini R; Gagnor A;
J Cardiovasc Transl Res; 2014 Feb; 7(1):101-11. PubMed ID: 24395497
[TBL] [Abstract][Full Text] [Related]
28. Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial.
Geisler T; Droppa M; Gawaz M; Steinhubl SR; Bertrand ME; Lincoff AM; Cequier AR; Desmet W; Rasmussen LH; Hoekstra JW; Bernstein D; Deliargyris EN; Mehran R; Stone GW
Catheter Cardiovasc Interv; 2016 Aug; 88(2):174-81. PubMed ID: 26332193
[TBL] [Abstract][Full Text] [Related]
29. Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials).
Ng VG; Baumbach A; Grinfeld L; Lincoff AM; Mehran R; Stone GW; Lansky AJ
Am J Cardiol; 2016 Jan; 117(2):186-91. PubMed ID: 26704028
[TBL] [Abstract][Full Text] [Related]
30. Bivalirudin versus unfractionated heparin during peripheral vascular interventions: A Propensity-matched Study.
Ortiz D; Singh M; Jahangir A; Allaqaband S; Khitha J; Bajwa TK; Mewissen MW
Catheter Cardiovasc Interv; 2017 Feb; 89(3):408-413. PubMed ID: 27526661
[TBL] [Abstract][Full Text] [Related]
31. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
Mehran R; Lansky AJ; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Wong SC; Nikolsky E; Gambone L; Vandertie L; Parise H; Dangas GD; Stone GW;
Lancet; 2009 Oct; 374(9696):1149-59. PubMed ID: 19717185
[TBL] [Abstract][Full Text] [Related]
32. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.
Steinberg DH; Shah P; Kinnaird T; Pinto Slottow TL; Roy PK; Okabe T; Bonello L; de Labriolle A; Smith KA; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Jul; 102(2):160-4. PubMed ID: 18602514
[TBL] [Abstract][Full Text] [Related]
33. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
Secemsky EA; Kirtane A; Bangalore S; Jovin IS; Shah RM; Ferro EG; Wimmer NJ; Roe M; Dai D; Mauri L; Yeh RW
JACC Cardiovasc Interv; 2016 Dec; 9(23):2376-2386. PubMed ID: 27838271
[TBL] [Abstract][Full Text] [Related]
34. Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population.
Shelton R; Eftychiou C; Somers K; Liu A; Burton-Wood N; Anderson M; Makri L; Blaxill J; McLenachan J; Wheatcroft S; Greenwood J; Blackman D
EuroIntervention; 2013 May; 9(1):118-24. PubMed ID: 23410540
[TBL] [Abstract][Full Text] [Related]
35. Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trial.
Hamon M; Coste P; Van't Hof A; Ten Berg J; Clemmensen P; Tabone X; Benamer H; Kristensen SD; Cavallini C; Marzocchi A; Hamm C; Kanic V; Bernstein D; Anthopoulos P; Deliargyris EN; Steg PG
Circ Cardiovasc Interv; 2015 Jun; 8(6):e002049. PubMed ID: 26056249
[TBL] [Abstract][Full Text] [Related]
36. Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes.
Gargiulo G; Carrara G; Frigoli E; Vranckx P; Leonardi S; Ciociano N; Campo G; Varbella F; Calabrò P; Garducci S; Iannone A; Briguori C; Andò G; Crimi G; Limbruno U; Garbo R; Sganzerla P; Russo F; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Zavalloni D; Santarelli A; Sardella G; Tresoldi S; de Cesare N; Sciahbasi A; Zingarelli A; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Valgimigli M
J Am Coll Cardiol; 2018 Mar; 71(11):1231-1242. PubMed ID: 29544607
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Zhang S; Gao W; Li H; Zou M; Sun S; Ba Y; Liu Y; Cheng G
Int J Cardiol; 2016 Apr; 209():87-95. PubMed ID: 26882192
[TBL] [Abstract][Full Text] [Related]
38. Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis.
Zhang J; Chen Z; Wang D; Li C; Luo F; He Y
Cardiol J; 2024; 31(2):309-320. PubMed ID: 37964648
[TBL] [Abstract][Full Text] [Related]
39. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
[TBL] [Abstract][Full Text] [Related]
40. Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting.
Briguori C; Visconti G; Focaccio A; Donahue M; Golia B; Selvetella L; Ricciardelli B
JACC Cardiovasc Interv; 2015 Mar; 8(3):414-423. PubMed ID: 25703878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]